AKT loss in human epithelial cells treated with severe hypoxia

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1803, Issue 8, 2010, Pages 951-959

  Box, Adrian Harold ^a,b   Kim, Sun Myoung ^a,b   Demetrick, Douglas James ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

Author keywords

AKT; Autophagy; Hypoxia; Inhibitor; Proteolysis

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 METHYLADENINE; CALPAIN; CASPASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN KINASE B; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 3-METHYLADENINE; ADENINE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; ISOPROTEIN; MORPHOLINE DERIVATIVE; MTOR PROTEIN, HUMAN; OXYGEN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TARGET OF RAPAMYCIN KINASE;

ARTICLE; AUTOPHAGY; CELL DEATH; CELL HYPOXIA; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME INHIBITION; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; ANOXIA; ANTAGONISTS AND INHIBITORS; CYTOLOGY; GENETICS; HELA CELL LINE; METABOLISM; PHYSIOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENINE; ANOXIA; AUTOPHAGY; CALPAIN; CHROMONES; ENZYME INHIBITORS; EPITHELIAL CELLS; HELA CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MORPHOLINES; OXYGEN; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; TOR SERINE-THREONINE KINASES;

EID: 77953712130     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2010.03.011     Document Type: Article

References (60)

1. Green S.L., Giaccia A.J. Tumor hypoxia and the cell cycle: implications for malignant progression and response to therapy. Cancer J. Sci. Am. 1998, 4:218-223.
2. Graeber T.G., Osmanian C., Jacks T., Housman D.E., Koch C.J., Lowe S.W., Giaccia A.J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996, 379:88-91.
3. Shimizu S., Eguchi Y., Kamiike W., Itoh Y., Hasegawa J., Yamabe K., Otsuki Y., Matsuda H., Tsujimoto Y. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL. Cancer Res. 1996, 56:2161-2166.
4. Shinzawa K., Tsujimoto Y. PLA2 activity is required for nuclear shrinkage in caspase-independent cell death. J. Cell Biol. 2003, 163:1219-1230.
5. Azad M.B., Chen Y., Henson E.S., Cizeau J., McMillan-Ward E., Israels S.J., Gibson S.B. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 2008, 4:195-204.
6. Wang G.L., Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 1993, 268:21513-21518.
7. Semenza G.L. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 2001, 13:167-171.
8. Jiang B.H., Jiang G., Zheng J.Z., Lu Z., Hunter T., Vogt P.K. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 2001, 12:363-369.
9. Engelman J.A. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat. Rev. Cancer 2009, 9:550-562.
10. Gonzalez E., McGraw T.E. The Akt kinases: isoform specificity in metabolism and cancer. Cell Cycle (Georgetown, Tex.) 2009, 8:2502-2508.
11. Scheid M.P., Marignani P.A., Woodgett J.R. Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B. Mol. Cell. Biol. 2002, 22:6247-6260.
12. Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science (New York, N.Y.) 2005, 307:1098-1101.
13. Downward J. PI 3-kinase, Akt and cell survival. Semin. Cell Dev. Biol. 2004, 15:177-182.
14. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
15. Kennedy S.G., Kandel E.S., Cross T.K., Hay N. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 1999, 19:5800-5810.
16. Degtyarev M., De Maziere A., Orr C., Lin J., Lee B.B., Tien J.Y., Prior W.W., van Dijk S., Wu H., Gray D.C., Davis D.P., Stern H.M., Murray L.J., Hoeflich K.P., Klumperman J., Friedman L.S., Lin K. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J. Cell Biol. 2008, 183:101-116.
17. Koseoglu S., Lu Z., Kumar C., Kirschmeier P., Zou J. AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines. Cancer Biol. Ther. 2007, 6:755-762.
18. Juntilla M.M., Wofford J.A., Birnbaum M.J., Rathmell J.C., Koretzky G.A. Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12105-12110.
19. Heron-Milhavet L., Franckhauser C., Rana V., Berthenet C., Fisher D., Hemmings B.A., Fernandez A., Lamb N.J. Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. Mol. Cell. Biol. 2006, 26:8267-8280.
20. Box A.H., Demetrick D.J. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Carcinogenesis 2004, 25:2325-2335.
21. Box A.H., Yuen C., Ponjevic D., Fick G.H., Demetrick D.J. Signaling and apoptosis differences between severe hypoxia and desferoxamine treatment of human epithelial cells. Biochem. Cell Biol. 2008, 86:425-436.
22. Andjelkovic M., Alessi D.R., Meier R., Fernandez A., Lamb N.J., Frech M., Cron P., Cohen P., Lucocq J.M., Hemmings B.A. Role of translocation in the activation and function of protein kinase B. J. Biol. Chem. 1997, 272:31515-31524.
23. Goldberg M.A., Glass G.A., Cunningham J.M., Bunn H.F. The regulated expression of erythropoietin by two human hepatoma cell lines. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:7972-7976.
24. Brodbeck D., Cron P., Hemmings B.A. A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain. J. Biol. Chem. 1999, 274:9133-9136.
25. Nanduri J., Wang N., Yuan G., Khan S.A., Souvannakitti D., Peng Y.J., Kumar G.K., Garcia J.A., Prabhakar N.R. Intermittent hypoxia degrades HIF-2alpha via calpains resulting in oxidative stress: implications for recurrent apnea-induced morbidities. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:1199-1204.
26. Kim Y.J., Yi Y., Sapp E., Wang Y., Cuiffo B., Kegel K.B., Qin Z.H., Aronin N., DiFiglia M. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:12784-12789.
27. Martinet W., De Meyer G.R. Autophagy in atherosclerosis. Curr. Atheroscler. Rep. 2008, 10:216-223.
28. Ekstrom P., Kanje M. Inhibition of fast axonal transport by erythro-9-[3-(2-hydroxynonyl)]adenine. J. Neurochem. 1984, 43:1342-1345.
29. Pursiheimo J.P., Rantanen K., Heikkinen P.T., Johansen T., Jaakkola P.M. Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62. Oncogene 2009, 28:334-344.
30. Liu L., Cash T.P., Jones R.G., Keith B., Thompson C.B., Simon M.C. Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol. Cell 2006, 21:521-531.
31. Arsham A.M., Howell J.J., Simon M.C. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J. Biol. Chem. 2003, 278:29655-29660.
32. Wouters B.G., van den Beucken T., Magagnin M.G., Koritzinsky M., Fels D., Koumenis C. Control of the hypoxic response through regulation of mRNA translation. Semin. Cell Dev. Biol. 2005, 16:487-501.
33. Basso A.D., Solit D.B., Chiosis G., Giri B., Tsichlis P., Rosen N. Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 2002, 277:39858-39866.
34. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.H., Hsu P.P., Bagley A.F., Markhard A.L., Sabatini D.M. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 2006, 22:159-168.
35. Nakatani K., Sakaue H., Thompson D.A., Weigel R.J., Roth R.A. Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem. Biophys. Res. Commun. 1999, 257:906-910.
36. Okano J., Gaslightwala I., Birnbaum M.J., Rustgi A.K., Nakagawa H. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J. Biol. Chem. 2000, 275:30934-30942.
37. Yang W.L., Wang J., Chan C.H., Lee S.W., Campos A.D., Lamothe B., Hur L., Grabiner B.C., Lin X., Darnay B.G., Lin H.K. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science (New York, N.Y.) 2009, 325:1134-1138.
38. Widmann C., Gibson S., Johnson G.L. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 1998, 273:7141-7147.
39. Adachi M., Katsumura K.R., Fujii K., Kobayashi S., Aoki H., Matsuzaki M. Proteasome-dependent decrease in Akt by growth factors in vascular smooth muscle cells. FEBS Lett. 2003, 554:77-80.
40. Medina E.A., Afsari R.R., Ravid T., Castillo S.S., Erickson K.L., Goldkorn T. TNF-alpha decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology 2005.
41. Asselin E., Mills G.B., Tsang B.K. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Cancer Res. 2001, 61:1862-1868.
42. Kim Y.-H., Park J.-W., Lee J.-Y., Surh Y.-J., Kwon T.K. Bcl-2 overexpression prevents daunorubicin-induced apoptosis through inhibition of XIAP and Akt degradation. Biochem. Pharmacol. 2003, 66:1779-1786.
43. Rokudai S., Naoya F., Hashimoto Y., Tsuruo T. Cleavage and inactivation of antiapoptotic Akt/PKB by caspases during apoptosis. J. Cell. Physiol. 2000, 182:290-296.
44. Riesterer O., Zingg D., Hummerjohann J., Bodis S., Pruschy M. Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells. Oncogene 2004, 23:4624-4635.
45. Martin D., Salinas M., Fujita N., Tsuruo T., Cuadrado A. Ceramide and reactive oxygen species generated by H2O2 induce caspase-3-independent degradation of Akt/protein kinase B. J. Biol. Chem. 2002, 277:42943-42952.
46. Lee B.L., Kim W.H., Jung J., Cho S.J., Park J.-W., Kim J., Chung H.-Y., Chang M.S., Nam S.Y. A hypoxia-independent up-regulation of hypoxia-inducible factor-1 by AKT contributes to angiogenesis in human gastric cancer. Carcinogenesis 2008, 29:44-51.
47. Alvarez-Tejado M., Naranjo-Suarez S., Jimenez C., Carrera A.C., Landazuri M.O., del Peso L. Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. J. Biol. Chem. 2001, 276:22368-22374.
48. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91:231-241.
49. Matsui T., Tao J., del Monte F., Lee K.H., Li L., Picard M., Force T.L., Franke T.F., Hajjar R.J., Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001, 104:330-335.
50. Arico S., Petiot A., Bauvy C., Dubbelhuis P.F., Meijer A.J., Codogno P., Ogier-Denis E. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 2001, 276:35243-35246.
51. Fujiwara K., Iwado E., Mills G.B., Sawaya R., Kondo S., Kondo Y. Akt inhibitor shows anticancer and radiosensitizing effects in malignant glioma cells by inducing autophagy. Int. J. Oncol. 2007, 31:753-760.
52. Liu X.H., Yu E.Z., Li Y.Y., Kagan E. HIF-1alpha has an anti-apoptotic effect in human airway epithelium that is mediated via Mcl-1 gene expression. J. Cell. Biochem. 2006, 97:755-765.
53. Brahimi-Horn C., Pouyssegur J. When hypoxia signalling meets the ubiquitin-proteasomal pathway, new targets for cancer therapy. Crit. Rev. Oncol. Hematol. 2005, 53:115-123.
54. Beitner-Johnson D., Rust R.T., Hsieh T.C., Millhorn D.E. Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells. Cell. Signal. 2001, 13:23-27.
55. Cho D.H., Lee H.J., Kim H.J., Hong S.H., Pyo J.O., Cho C., Jung Y.K. Suppression of hypoxic cell death by APIP-induced sustained activation of AKT and ERK1/2. Oncogene 2007, 26:2809-2814.
56. Wykoff C.C., Pugh C.W., Maxwell P.H., Harris A.L., Ratcliffe P.J. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene 2000, 19:6297-6305.
57. Koong A.C., Denko N.C., Hudson K.M., Schindler C., Swiersz L., Koch C., Evans S., Ibrahim H., Le Q.T., Terris D.J., Giaccia A.J. Candidate genes for the hypoxic tumor phenotype. Cancer Res. 2000, 60:883-887.
58. Laughner E., Taghavi P., Chiles K., Mahon P.C., Semenza G.L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 2001, 21:3995-4004.
59. Papandreou I., Krishna C., Kaper F., Cai D., Giaccia A.J., Denko N.C. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res. 2005, 65:3171-3178.
60. Dayan F., Bilton R.L., Laferriere J., Trottier E., Roux D., Pouyssegur J., Mazure N.M. Activation of HIF-1alpha in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway. J. Cell. Physiol. 2009, 218:167-174.